• Startup Pulse
    altM raises $10.3 million in a Series A round led by Rainmatter by Zerodha and Mela Ventures, with Omnivore, Theia Ventures, Aureolis Ventures, Spectrum Impact and strategic angel investors participating. Venomics AI raises $2.7 million in a pre-seed round co-led by Speciale Invest and South Park Commons, with Operators Studio participating. EloElo Group raises $80 million in a Series C round led by Hornbill Capital and NBCUniversal, with MIT Investment Co. and existing investors participating. Peppermint Robotics raises ₹100 crore (approximately $10.5 million) in a Pre-Series B round led by pi Ventures and Crane Venture Partners, with Asiana Fund participating. Traversal raises $120 million in a Series B round at a $1 billion valuation, led by Kleiner Perkins, Redpoint and Khosla Ventures, with Sequoia Capital, Battery Ventures and Amex Ventures participating. GIVA raises over $100 million in a round led by Multiples Alternate Asset Management. The Croffle Guys raises ₹14 crore in a round led by V3 Ventures, with N.A.N Partners participating. Solgram raises over $1 million in a pre-seed round led by DSG Consumer Partners and Saama Capital, with Kapil Chopra participating. Sachin Tendulkar makes a strategic investment in Metasports Interactive, the company behind Hitwicket. The amount was not disclosed. Hyeglo Beauty raises ₹7 crore in a round led by Sauce, with Giga Capital, Consumer Collective, Reckitt's Arjun Purkayastha and The Patient Capital participating. altM raises $10.3 million in a Series A round led by Rainmatter by Zerodha and Mela Ventures, with Omnivore, Theia Ventures, Aureolis Ventures, Spectrum Impact and strategic angel investors participating. Venomics AI raises $2.7 million in a pre-seed round co-led by Speciale Invest and South Park Commons, with Operators Studio participating. EloElo Group raises $80 million in a Series C round led by Hornbill Capital and NBCUniversal, with MIT Investment Co. and existing investors participating. Peppermint Robotics raises ₹100 crore (approximately $10.5 million) in a Pre-Series B round led by pi Ventures and Crane Venture Partners, with Asiana Fund participating. Traversal raises $120 million in a Series B round at a $1 billion valuation, led by Kleiner Perkins, Redpoint and Khosla Ventures, with Sequoia Capital, Battery Ventures and Amex Ventures participating. GIVA raises over $100 million in a round led by Multiples Alternate Asset Management. The Croffle Guys raises ₹14 crore in a round led by V3 Ventures, with N.A.N Partners participating. Solgram raises over $1 million in a pre-seed round led by DSG Consumer Partners and Saama Capital, with Kapil Chopra participating. Sachin Tendulkar makes a strategic investment in Metasports Interactive, the company behind Hitwicket. The amount was not disclosed. Hyeglo Beauty raises ₹7 crore in a round led by Sauce, with Giga Capital, Consumer Collective, Reckitt's Arjun Purkayastha and The Patient Capital participating.
  • Fermenta Biotech Granted Patent for Sustainable Plant-Based Vitamin D3 Manufacturing

    Fermenta Biotech

    Thane: Fermenta Biotech Limited (BSE: 506414) (Bloomberg: FERMENTA:IN) (Reuters: FERM.BO), an Indian manufacturer of active pharmaceutical ingredients (APIs), intermediates, and nutritional premixes, has announced that the Indian Patent Office has officially granted a patent for its in-house developed plant-based Vitamin D3 process.

    The newly granted patent secures Fermenta Biotech’s proprietary process for producing plant-based Vitamin D3, representing a major advancement in its innovation pipeline.

    This breakthrough reinforces the company’s position as a global leader in the Vitamin D3 domain, particularly with vegan and vegetarian-friendly alternatives, as consumer demand for sustainable, ethically sourced nutrition continues to accelerate.

    Also Read: Manufacturing Innovation: Godrej Tooling Secures Three New Patents

    Fermenta Biotech: Supporting Vegan and Sustainable Vitamin D3 Solutions

    By enabling the commercial production of 100% plant-based Vitamin D3, Fermenta Biotech is set to address emerging opportunities in nutraceuticals and food fortification.

    Plant-derived ingredients are gaining significant traction worldwide, commanding premium value in the nutrition sector due to their sustainability and ethical sourcing.

    Prashant Nagre, Managing Director of Fermenta Biotech, commented: “The grant of this patent is a proud milestone in our journey of innovation. It reflects our commitment to delivering environmentally conscious solutions that align with evolving consumer needs.

    Plant-based Vitamin D3 represents the future of nutrition, and this patent strengthens our ability to create differentiated offerings that generate long-term value for our partners and society at large. It also underscores India’s potential as a hub for pioneering industrial innovation in global wellness.”

    Also Read: Biostate AI Secures Global Collaborations to Advance RNA-Based Precision Medicine

    Expanding Fermenta Biotech’s Innovation Legacy

    This patent not only fortifies Fermenta Biotech’s competitive advantage but also builds upon its pioneering legacy in biotechnology and nutrition.

    With its expanding portfolio – including Customized Premixes, Fortified Rice Kernel (FRK), and other nutritional ingredients – the company continues to contribute toward closing global nutrition gaps while upholding its principles of sustainability and scientific excellence.

    Founded in 1951, Fermenta Biotech Limited is a leading innovator in nutrition, APIs, and premixes, with a strong emphasis on sustainable and plant-based solutions for global markets.

    Author

    • Salil Urunkar

      Salil Urunkar is a senior journalist and the editorial mind behind Sahyadri Startups. With years of experience covering Pune’s entrepreneurial rise, he’s passionate about telling the real stories of founders, disruptors, and game-changers.

    Back to top